Blast at pharma company leaves one dead, six injured

Published On 2025-06-17 11:23 GMT | Update On 2025-06-17 11:23 GMT

Nagpur: Tragedy struck a pharma company's unit in Nagpur district on Tuesday when a blast occurred in a glass line reactor, killing one person and injuring six others, police said.

The explosion happened at around 11 a.m. at the unit of Ankit Pulps and Boards Pvt Ltd, located in Bhilgaon, a senior police official told PTI. The cause of the blast was not known.

All the injured are undergoing treatment at a hospital in nearby Kamptee town and one of them is in critical condition, he informed.

The company is engaged in the manufacturing of microcrystalline cellulose (MCC) which is used in pharmaceutical and food industries. MCC is primarily used as an excipient1 (binder/filler) in the pharmaceutical industry.

According to its website, the firm delves into the manufacture of excipients for use in diverse pharmaceutical segments.

In recent months, there have been other reported incidents in the pharmaceutical manufacturing sector.

In May, a fire incident occurred at a GlaxoSmithKline Pharmaceuticals Limited (GSK) contract manufacturing facility, leading to a temporary production disruption of operations at that site.

Earlier, at the end of April, a fire broke out at the Penicillin G manufacturing facility of Lyfius Pharma Private Limited, a subsidiary of Aurobindo Pharma, located in the Kakinada SEZ, Andhra Pradesh, reportedly caused by the self-ignition of coal.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Blast at pharma company leaves one dead, six injured

Similar News

Health crisis in a bottle: Rajasthan govt bans cough syrup batch after patients fall ill in Bharatpur, Sikar

Not All Combipacks Are New Drugs: CDSCO Defines Approval Rules for Lyophilized Injections

Fake docs, real jobs: Pharmacist at Community Health Centre in Ballia booked in recruitment scam

Wockhardt seeks USFDA approval for Zidebactam-Cefepime injection to treat Serious GramNegative Infections

Biocon Biologics, Amgen strike settlement, clear path for Bosaya, Aukelso in US

Lupin bags USFDA approval for Rivaroxaban for Oral Suspension for thromboprophylaxis in pediatric patients

Bombay HC Quashes Maharashtra FDA, CDSCO Stop-Production Orders Against 2 Pharma Firms

Indian Immunologicals Launches Raksha-IBR, India's First DIVA Vaccine Against IBR